The UCCRC Transgenic Mouse/Embryonic Stem Cell Facility provides comprehensive genetic
engineering services to alter the genome of the laboratory mouse. The UCCRC has many investigators
who use mouse models as their primary tool of analysis, as well as a multitude of additional
investigators who require the occasional mouse model in their studies of the causes and treatment of
cancer. The generation and maintenance of transgenic animals through the microinjection of singlecelled
mouse embryos, and the generation of genetically modified mice through the use of ES cells
require specialized technical personnel. Furthermore, such efforts necessitate the acquisition of an
array of devoted equipment. Thus, the availability of a shared facility greatly reduces research costs for
the individual investigators of the UCCRC. The existence of this facility also greatly increases the
accessibility of genetic engineering technology to investigators with limited related experience.
The UCCRC Transgenic Mouse/Embryonic Stem Cell Facility was established in 1991, and has been
tremendously productive and successful; the range of services provided has expanded considerably
since its founding. Nine services are provided by the Transgenic Mouse/Embryonic Stem Cell Facility:
(1) transgenic mouse production from founder through F1 Stage; (2) ES cell technology mouse
production; (3) ES cell gene targeting and culturing; (4) mouse embryonic feeder (MEF) cell production;
(5) Timed pregnancies of various strains and lines of mice; (6) embryo rederivation; (7) ES cell line
development; (8) various breeding services and GEM model line maintenance; and (9) DMA
preparation from ES cell lines for the construction of a gene targeting construct. In addition to the
technical services, the Facility also offers assistance with the design of studies that require mouse
molecular genetics and an annual course in Mouse Handling and Breeding. This course covers
information regarding analysis and handling of the mice once the Facility has generated them, as well
as general breeding and handling procedures for mice. In providing these comprehensive services, the
UCCRC Transgenic Mouse/Embryonic Stem Cell Facility has generated mouse models that have led to
advances in our understanding of cancer, including cancers of the breast, skin, colon, brain and
hematopoietic system.
Public Health Relevance Statement
Data not available.
NIH Spending Category
BiotechnologyCancer**Genetics
Project Terms
BrainBreedingCancer CenterCellsChicagoColonDevelopmentES Cell LineEmbryoEquipmentFacility Construction Funding CategoryFacultyFemaleGene Expression RegulationGene TargetingGenerationsGenetic EngineeringGenomeGenus ColaHematopoietic SystemHuman ResourcesIndividualInjection of therapeutic agentLaboratory miceMaintenanceMalignant NeoplasmsMicroinjectionsModelingMolecular GeneticsMusNumbersPatient currently pregnantPregnancyPreparationProceduresProductionRangeResearchResearch DesignResearch PersonnelServicesSignal TransductionSkinStagingTechnologyTimeTransgenic AnimalsTransgenic MiceUniversitiesUniversity of Chicago Cancer Research Centeranimal resourceblastocystcancer therapycostembryonic stem cellexperiencemalignant breast neoplasmmembermouse modelprogramsresearch facilitytool
No Sub Projects information available for 2P30CA014599-33 9010
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P30CA014599-33 9010
Patents
No Patents information available for 2P30CA014599-33 9010
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P30CA014599-33 9010
Clinical Studies
No Clinical Studies information available for 2P30CA014599-33 9010
News and More
Related News Releases
No news release information available for 2P30CA014599-33 9010
History
No Historical information available for 2P30CA014599-33 9010
Similar Projects
No Similar Projects information available for 2P30CA014599-33 9010